is jardiance a glp-1 drug Do The Benefits of Drugs OutWeigh the Negatives? U.S. FDA approves Jardiance® (empagliflozin)

Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.

Explore the implications of proposed changes to GLP-1 medication coverage and their impact on Medicare and Medicaid health plans

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

ConclusionGLP-1 medications can be a helpful tool for weight loss, but theyre not a one-size-fits-all solution

Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway